Literature DB >> 12412797

Bisphosphonate induces remission of refractory osteolysis in langerhans cell histiocytosis.

Junji Kamizono1, Yosuke Okada, Akira Shirahata, Yoshiya Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12412797     DOI： 10.1359/jbmr.2002.17.11.1926

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  11 in total

1.  Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Gregory A Kaltsas; Georgios Delimpasis; Ludwig Wilkens; George Kanakis; Polyzois Makras
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.

Authors:  Shanthi Sivendran; Harold Harvey; Allan Lipton; Joseph Drabick
Journal:  Int J Hematol       Date:  2011-04-26       Impact factor: 2.490

3.  Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action.

Authors:  Thitinan Srikulmontree; H Davis Massey; W Neal Roberts
Journal:  Rheumatol Int       Date:  2006-08-25       Impact factor: 2.631

Review 4.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

5.  Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis.

Authors:  Liliana Montella; Carmela Merola; Geraldina Merola; Luigi Petillo; Giovannella Palmieri
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

Review 6.  Macrophages: Their Emerging Roles in Bone.

Authors:  Benjamin P Sinder; Allison R Pettit; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2015-12       Impact factor: 6.741

7.  Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.

Authors:  Sanda Alexandrescu; Nina Tatevian; Bogdan A Czerniak; Michael H Covinsky; Nadja K Burns; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

8.  Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.

Authors:  Deepak Chellapandian; Polyzois Makras; Gregory Kaltsas; Cor van den Bos; Lamia Naccache; Raajit Rampal; Anne-Sophie Carret; Sheila Weitzman; R Maarten Egeler; Oussama Abla
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-07-01       Impact factor: 2.576

Review 9.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12

Review 10.  Merkel cell polyomavirus and Langerhans cell neoplasm.

Authors:  Ichiro Murakami; Noriko Wada; Junko Nakashima; Mitsuko Iguchi; Makoto Toi; Yumiko Hashida; Tomonori Higuchi; Masanori Daibata; Michiko Matsushita; Takeshi Iwasaki; Satoshi Kuwamoto; Yasushi Horie; Keiko Nagata; Kazuhiko Hayashi; Takashi Oka; Tadashi Yoshino; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Jean Gogusev; Francis Jaubert
Journal:  Cell Commun Signal       Date:  2018-08-22       Impact factor: 5.712
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.